News
SMMBF
4.320
NaN%
--
UBS Remains a Buy on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
TipRanks · 2d ago
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from DBS
TipRanks · 3d ago
Citi Keeps Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
TipRanks · 4d ago
MicroPort MedBot Forecasts First Semi-Annual Profit on Surging Robot Sales
TipRanks · 5d ago
MicroPort MedBot’s Toumai Surgical Robot Tops 200 Global Installations
TipRanks · 06/26 15:21
MicroPort MedBot Wins Landmark EU CE Mark for Toumai Remote Surgical Robot
TipRanks · 06/21 22:37
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from UBS
TipRanks · 06/19 00:22
MicroPort MedBot’s Toumai Surgical Robot Surpasses 300 Global Orders as Remote Surgery Push Accelerates
TipRanks · 06/16 23:01
Shanghai MicroPort MedBot Wins Shareholder Backing for Profit Plan and Capital Mandates
TipRanks · 06/05 14:38
Citi Reaffirms Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
TipRanks · 05/30 14:35
Guotai Haitong Sticks to Their Buy Rating for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
TipRanks · 05/30 00:42
MicroPort MedBot Proposes New Share Scheme to Replace Existing Incentive Plans
TipRanks · 05/14 13:12
MicroPort MedBot Sets 2026 AGM With New Capital Mandates on the Table
TipRanks · 05/14 13:11
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from Citic Securities
TipRanks · 05/14 00:35
More
Webull provides a variety of real-time SMMBF stock news. You can receive the latest news about Shanghai Microport Medbot Gp C through multiple platforms. This information may help you make smarter investment decisions.
About SMMBF
Shanghai MicroPort MedBot (Group) Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sale of surgical robots. The Company's business covers the fields of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The Company's products include Toumai LaparoscopicSurgical Robot, Toumai Single-port Laparoscopic Surgical Robot, DFVision Three Dimensions (3D) Electronic Laparoscope, SkyWalker Orthopedic Surgical Robot, Trans-bronchial Surgical Robot, R-ONE Vascular Interventional Robot, and iSR’obot Mona Lisa RoboticTransperineal Prostate Biopsy System. The Company conducts its businesses in domestic and overseas markets.